Global Age-related Macular Degeneration Market Analysis 2015-2019 and Forecast 2020-2025
- 99S3753812
- 86 Pages
- February 2020
- Healthcare
The global Age-related Macular Degeneration market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Age-related Macular Degeneration by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Wet AMD
Dry AMD
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Bayer HealthCare
F. Hoffmann-La Roche
Novartis
Regeneron Pharmaceuticals
Alcon
Allergan
Avalanche
Bausch+Lomb
Gilead Sciences
Iconic Therapeutics
Neurotech Pharmaceuticals
Ohr Pharmaceutical
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Drugstore
Hospital
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
1 Industry Overview
1.1 Age-related Macular Degeneration Industry
Figure Age-related Macular Degeneration Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Age-related Macular Degeneration
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Age-related Macular Degeneration
1.2.2 Downstream
Table Application Segment of Age-related Macular Degeneration
Table Global Age-related Macular Degeneration Market 2015-2025, by Application, in USD Million
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Age-related Macular Degeneration Market by Type
3.1 By Type
3.1.1 Wet AMD
Table Major Company List of Wet AMD
3.1.2 Dry AMD
Table Major Company List of Dry AMD
3.2 Market Size
Table Global Age-related Macular Degeneration Market 2015-2019, by Type, in USD Million
Figure Global Age-related Macular Degeneration Market Growth 2015-2019, by Type, in USD Million
Table Global Age-related Macular Degeneration Market 2015-2019, by Type, in Volume
Figure Global Age-related Macular Degeneration Market Growth 2015-2019, by Type, in Volume
3.3 Market Forecast
Table Global Age-related Macular Degeneration Market Forecast 2020-2025, by Type, in USD Million
Table Global Age-related Macular Degeneration Market Forecast 2020-2025, by Type, in Volume
4 Major Companies List
4.1 Bayer HealthCare (Company Profile, Sales Data etc.)
4.1.1 Bayer HealthCare Profile
Table Bayer HealthCare Overview List
4.1.2 Bayer HealthCare Products & Services
4.1.3 Bayer HealthCare Business Operation Conditions
Table Business Operation of Bayer HealthCare (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 F. Hoffmann-La Roche (Company Profile, Sales Data etc.)
4.2.1 F. Hoffmann-La Roche Profile
Table F. Hoffmann-La Roche Overview List
4.2.2 F. Hoffmann-La Roche Products & Services
4.2.3 F. Hoffmann-La Roche Business Operation Conditions
Table Business Operation of F. Hoffmann-La Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Novartis (Company Profile, Sales Data etc.)
4.3.1 Novartis Profile
Table Novartis Overview List
4.3.2 Novartis Products & Services
4.3.3 Novartis Business Operation Conditions
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Regeneron Pharmaceuticals (Company Profile, Sales Data etc.)
4.4.1 Regeneron Pharmaceuticals Profile
Table Regeneron Pharmaceuticals Overview List
4.4.2 Regeneron Pharmaceuticals Products & Services
4.4.3 Regeneron Pharmaceuticals Business Operation Conditions
Table Business Operation of Regeneron Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Alcon (Company Profile, Sales Data etc.)
4.5.1 Alcon Profile
Table Alcon Overview List
4.5.2 Alcon Products & Services
4.5.3 Alcon Business Operation Conditions
Table Business Operation of Alcon (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Allergan (Company Profile, Sales Data etc.)
4.6.1 Allergan Profile
Table Allergan Overview List
4.6.2 Allergan Products & Services
4.6.3 Allergan Business Operation Conditions
Table Business Operation of Allergan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Avalanche (Company Profile, Sales Data etc.)
4.7.1 Avalanche Profile
Table Avalanche Overview List
4.7.2 Avalanche Products & Services
4.7.3 Avalanche Business Operation Conditions
Table Business Operation of Avalanche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Bausch+Lomb (Company Profile, Sales Data etc.)
4.8.1 Bausch+Lomb Profile
Table Bausch+Lomb Overview List
4.8.2 Bausch+Lomb Products & Services
4.8.3 Bausch+Lomb Business Operation Conditions
Table Business Operation of Bausch+Lomb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Gilead Sciences (Company Profile, Sales Data etc.)
4.9.1 Gilead Sciences Profile
Table Gilead Sciences Overview List
4.9.2 Gilead Sciences Products & Services
4.9.3 Gilead Sciences Business Operation Conditions
Table Business Operation of Gilead Sciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Iconic Therapeutics (Company Profile, Sales Data etc.)
4.10.1 Iconic Therapeutics Profile
Table Iconic Therapeutics Overview List
4.10.2 Iconic Therapeutics Products & Services
4.10.3 Iconic Therapeutics Business Operation Conditions
Table Business Operation of Iconic Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Neurotech Pharmaceuticals (Company Profile, Sales Data etc.)
4.11.1 Neurotech Pharmaceuticals Profile
Table Neurotech Pharmaceuticals Overview List
4.11.2 Neurotech Pharmaceuticals Products & Services
4.11.3 Neurotech Pharmaceuticals Business Operation Conditions
Table Business Operation of Neurotech Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Ohr Pharmaceutical (Company Profile, Sales Data etc.)
4.12.1 Ohr Pharmaceutical Profile
Table Ohr Pharmaceutical Overview List
4.12.2 Ohr Pharmaceutical Products & Services
4.12.3 Ohr Pharmaceutical Business Operation Conditions
Table Business Operation of Ohr Pharmaceutical (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Age-related Macular Degeneration Sales Revenue 2015-2019, by Company, in USD Million
Table Global Age-related Macular Degeneration Sales Revenue Share 2015-2019, by Company, in USD Million
Figure Global Age-related Macular Degeneration Sales Revenue Share in 2019, by Company, in USD Million
Table Global Age-related Macular Degeneration Sales Volume 2015-2019, by Company, in Volume
Table Global Age-related Macular Degeneration Sales Volume Share 2015-2019, by Company, in Volume
Figure Global Age-related Macular Degeneration Sales Volume Share in 2019, by Company, in Volume
5.2 Regional Market by Company
Figure North America Age-related Macular Degeneration Market Concentration, in 2019
Figure Europe Age-related Macular Degeneration Market Market Concentration, in 2019
Figure Asia-Pacific Age-related Macular Degeneration MMarket Concentration, in 2019
Figure South America Age-related Macular Degeneration Market Concentration, in 2019
Figure Middle East & Africa Age-related Macular Degeneration Market Concentration, in 2019
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Drugstore
Figure Age-related Macular Degeneration Demand in Drugstore, 2015-2019, in USD Million
Figure Age-related Macular Degeneration Demand in Drugstore, 2015-2019, in Volume
6.1.2 Demand in Hospital
Figure Age-related Macular Degeneration Demand in Hospital, 2015-2019, in USD Million
Figure Age-related Macular Degeneration Demand in Hospital, 2015-2019, in Volume
6.1.3 Demand in Others
Figure Age-related Macular Degeneration Demand in Others, 2015-2019, in USD Million
Figure Age-related Macular Degeneration Demand in Others, 2015-2019, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Age-related Macular Degeneration Demand Forecast 2020-2025, by Application, in USD Million
Figure Age-related Macular Degeneration Market Growth 2020-2025, by Application, in USD Million
Figure Age-related Macular Degeneration Market Share in 2025, by Application, in USD Million
Table Age-related Macular Degeneration Demand Forecast 2020-2025, by Application, in Volume
Table Age-related Macular Degeneration Market Growth 2020-2025, by Application, in Volume
Table Age-related Macular Degeneration Market Share in 2025, by Application, in Volume
7 Region Operation
7.1 Regional Production
Table Age-related Macular Degeneration Production 2015-2019, by Region, in USD Million
Table Age-related Macular Degeneration Production 2015-2019, by Region, in Volume
7.2 Regional Market
Table Global Age-related Macular Degeneration Market 2015-2019, by Region, in USD Million
Table Global Age-related Macular Degeneration Market Share 2015-2019, by Region, in USD Million
Table Global Age-related Macular Degeneration Market 2015-2019, by Region, in Volume
Table Global Age-related Macular Degeneration Market Share 2015-2019, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Age-related Macular Degeneration Market Size and Growth 2015-2019, in USD Million
Figure North America Age-related Macular Degeneration Market Size and Growth 2015-2019, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Age-related Macular Degeneration Market Size 2015-2019, by Country, in USD Million
Table North America Age-related Macular Degeneration Market Size 2015-2019, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Age-related Macular Degeneration Market Size and Growth 2015-2019, in USD Million
Figure Europe Age-related Macular Degeneration Market Size and Growth 2015-2019, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Age-related Macular Degeneration Market Size 2015-2019, by Country, in USD Million
Table Europe Age-related Macular Degeneration Market Size 2015-2019, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Age-related Macular Degeneration Market Size and Growth 2015-2019, in USD Million
Figure Asia-Pacific Age-related Macular Degeneration Market Size and Growth 2015-2019, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Age-related Macular Degeneration Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Age-related Macular Degeneration Market Size 2015-2019, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Age-related Macular Degeneration Market Size and Growth 2015-2019, in USD Million
Figure South America Age-related Macular Degeneration Market Size and Growth 2015-2019, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Age-related Macular Degeneration Market Size 2015-2019, by Country, in USD Million
Table South America Age-related Macular Degeneration Market Size 2015-2019, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Age-related Macular Degeneration Market Size and Growth 2015-2019, in USD Million
Figure Middle East & Africa Age-related Macular Degeneration Market Size and Growth 2015-2019, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Age-related Macular Degeneration Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Age-related Macular Degeneration Market Size 2015-2019, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Age-related Macular Degeneration Market Forecast 2020-2025, by Region, in USD Million
Table Age-related Macular Degeneration Market Forecast 2020-2025, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
Table Upstream Segment of Age-related Macular Degeneration
Table Application Segment of Age-related Macular Degeneration
Table Global Age-related Macular Degeneration Market 2015-2025, by Application, in USD Million
Table Major Company List of Dry AMD
Table Global Age-related Macular Degeneration Market 2015-2019, by Type, in USD Million
Table Global Age-related Macular Degeneration Market 2015-2019, by Type, in Volume
Table Global Age-related Macular Degeneration Market Forecast 2020-2025, by Type, in USD Million
Table Global Age-related Macular Degeneration Market Forecast 2020-2025, by Type, in Volume
Table Bayer HealthCare Overview List
Table Business Operation of Bayer HealthCare (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table F. Hoffmann-La Roche Overview List
Table Business Operation of F. Hoffmann-La Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Overview List
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Regeneron Pharmaceuticals Overview List
Table Business Operation of Regeneron Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Alcon Overview List
Table Business Operation of Alcon (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Allergan Overview List
Table Business Operation of Allergan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Avalanche Overview List
Table Business Operation of Avalanche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bausch+Lomb Overview List
Table Business Operation of Bausch+Lomb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gilead Sciences Overview List
Table Business Operation of Gilead Sciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Iconic Therapeutics Overview List
Table Business Operation of Iconic Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Neurotech Pharmaceuticals Overview List
Table Business Operation of Neurotech Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ohr Pharmaceutical Overview List
Table Business Operation of Ohr Pharmaceutical (Sales Revenue, Cost, Gross Margin)
Table Global Age-related Macular Degeneration Sales Revenue 2015-2019, by Company, in USD Million
Table Global Age-related Macular Degeneration Sales Revenue Share 2015-2019, by Company, in USD Million
Table Global Age-related Macular Degeneration Sales Volume 2015-2019, by Company, in Volume
Table Global Age-related Macular Degeneration Sales Volume Share 2015-2019, by Company, in Volume
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Age-related Macular Degeneration Demand Forecast 2020-2025, by Application, in USD Million
Table Age-related Macular Degeneration Demand Forecast 2020-2025, by Application, in Volume
Table Age-related Macular Degeneration Market Growth 2020-2025, by Application, in Volume
Table Age-related Macular Degeneration Market Share in 2025, by Application, in Volume
Table Age-related Macular Degeneration Production 2015-2019, by Region, in USD Million
Table Age-related Macular Degeneration Production 2015-2019, by Region, in Volume
Table Global Age-related Macular Degeneration Market 2015-2019, by Region, in USD Million
Table Global Age-related Macular Degeneration Market Share 2015-2019, by Region, in USD Million
Table Global Age-related Macular Degeneration Market 2015-2019, by Region, in Volume
Table Global Age-related Macular Degeneration Market Share 2015-2019, by Region, in Volume
Table North America Age-related Macular Degeneration Market Size 2015-2019, by Country, in USD Million
Table North America Age-related Macular Degeneration Market Size 2015-2019, by Country, in Volume
Table Europe Age-related Macular Degeneration Market Size 2015-2019, by Country, in USD Million
Table Europe Age-related Macular Degeneration Market Size 2015-2019, by Country, in Volume
Table Asia-Pacific Age-related Macular Degeneration Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Age-related Macular Degeneration Market Size 2015-2019, by Country, in Volume
Table South America Age-related Macular Degeneration Market Size 2015-2019, by Country, in USD Million
Table South America Age-related Macular Degeneration Market Size 2015-2019, by Country, in Volume
Table Middle East & Africa Age-related Macular Degeneration Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Age-related Macular Degeneration Market Size 2015-2019, by Country, in Volume
Table Age-related Macular Degeneration Market Forecast 2020-2025, by Region, in USD Million
Table Age-related Macular Degeneration Market Forecast 2020-2025, by Region, in Volume
Table Price Factors List
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
